These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 30325549)

  • 1. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement.
    Radovic N; Ivanac G; Divjak E; Biondic I; Bulum A; Brkljacic B
    J Magn Reson Imaging; 2019 May; 49(5):1381-1390. PubMed ID: 30325549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
    Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
    J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers.
    Kishimoto AO; Kataoka M; Iima M; Honda M; Miyake KK; Ohashi A; Ota R; Kataoka T; Sakurai T; Toi M; Togashi K
    Magn Reson Imaging; 2020 Sep; 71():161-169. PubMed ID: 32320723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution diffusion-weighted imaging compared with conventional diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging with regard to image quality and assessment of breast cancer morphology.
    Metin Y; Orhan Metin N; Kul S; Taşçı F; Özdemir O; Küpeli A
    Diagn Interv Radiol; 2023 Mar; 29(2):251-259. PubMed ID: 36987843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
    Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
    J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver agreement of PI-RADS v. 2 lexicon among radiologists with different levels of experience.
    Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DZ; Leão LRS; Luz DC; Martins T; Baroni RH
    J Magn Reson Imaging; 2020 Feb; 51(2):593-602. PubMed ID: 31369194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
    Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
    Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.
    Ikeda DM; Hylton NM; Kinkel K; Hochman MG; Kuhl CK; Kaiser WA; Weinreb JC; Smazal SF; Degani H; Viehweg P; Barclay J; Schnall MD
    J Magn Reson Imaging; 2001 Jun; 13(6):889-95. PubMed ID: 11382949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response.
    Abdelrahman AS; Ekladious MEY; Badran EM; Madkour SS
    Diagn Interv Imaging; 2022 Nov; 103(11):524-534. PubMed ID: 35787988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast lesion morphology assessment with high and standard b values in diffusion-weighted imaging at 3 Tesla.
    Christner SA; Grunz JP; Schlaiß T; Curtaz C; Kunz AS; Huflage H; Patzer TS; Bley TA; Sauer ST
    Magn Reson Imaging; 2024 Apr; 107():100-110. PubMed ID: 38246517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.